Cargando…
Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study
BACKGROUND: The prognosis of patients with metastatic or advanced sarcomas is poor and there are few options for treatment. Several studies have shown that gemcitabine and docetaxel (GD) combination chemotherapy has antitumor activity against various subtypes of sarcoma. Recently, some studies have...
Autores principales: | Hara, Hitomi, Kawamoto, Teruya, Fukase, Naomasa, Kawakami, Yohei, Takemori, Toshiyuki, Fujiwara, Shuichi, Kitayama, Kazumichi, Nishida, Kotaro, Kuroda, Ryosuke, Akisue, Toshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651911/ https://www.ncbi.nlm.nih.gov/pubmed/31337342 http://dx.doi.org/10.1186/s12885-019-5923-7 |
Ejemplares similares
-
Huge chronic expanding hematoma of the iliac bone following multiple hip surgeries: a case report
por: Morishita, Masayuki, et al.
Publicado: (2018) -
Chondrolipoma of the finger in a child: A case study
por: Mitani, Kazuyoshi, et al.
Publicado: (2021) -
Clinical Outcomes and Prognostic Factors in Soft Tissue Sarcoma Patients After Unplanned Excision
por: Takemori, Toshiyuki, et al.
Publicado: (2022) -
Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis
por: Kitayama, Kazumichi, et al.
Publicado: (2021) -
Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors
por: Fujiwara, Shuichi, et al.
Publicado: (2020)